Scientist – Drug-Drug Interactions

We are hiring a Scientist, Drug-Drug Interactions for a one-year fixed-term position, with experience in several of the following: designing/planning of assays, cell culturing (2D/3D), cell-based assays (FL/Lum/other endpoints), qPCR, enzyme kinetics and/or in vitro drug-drug interaction -related methodologies. We also expect good written and oral communication skills since the position requires working closely with other team members.

In this position, you will be responsible for part of the preclinical DDI, permeation and (in vitro) toxicity studies we perform for our customers. You will provide guidance and support to laboratory technicians and collaborate with other scientists in the team. You will process and analyze the results and prepare reports together with the senior scientist within each project.

You have a university degree MSc or PhD in a suitable field (e.g. pharmacy, biochemistry, cell biology, toxicology), with work experience relevant to the position. Experience in ADME/pharmacology as well as understanding of the methodologies employed in preclinical pharmacokinetic studies are considered as an advantage.

We offer an interesting, versatile and challenging position in a strongly growing company with a great atmosphere, and colleagues across our global organization. Furthermore, you will have an opportunity to be part of a continuously evolving drug development landscape. The position is available at our site in Oulu, Finland (on-site required).

Admescope (www.admescope.com) provides research services to pharmaceutical companies and contributes to the discovery and development of new therapies to promote peoples health. The special expertise of the growing company is in drug metabolism, drug-drug interactions, quantitative bioanalysis, pharmacokinetic studies, and toxicology. The company offers versatile and challenging tasks as a partner of international pharmaceutical and biotech companies. Admescope (Symeres Finland Oy), initially of Finnish origin from 2011, is part of the Dutch company Symeres, which totally employs approximately 600 people in the Netherlands, Finland, the Czech Republic, and the USA (www.symeres.com).